Muna Anwar Alnimri, M.B.B.S. for UC Davis Health

Muna Anwar Alnimri, M.B.B.S.

Associate Professor, Department of Medicine

To see if Muna Anwar Alnimri is accepting new patients, or for assistance finding a UC Davis doctor, please call 800-2-UCDAVIS (800-282-3284).




Surgery - Transplant


Internal Medicine

Locations and Contact

UC Davis Medical Center

UC Davis Medical Center
2315 Stockton Blvd.
Sacramento, CA 95817

Get Directions

Additional Numbers

Clinic Phone


Clinic Phone


Clinic Fax


Clinic Referral Phone


Physician Referrals

800-4-UCDAVIS (800-482-3284)

Philosophy of Care

Dr. Alnimri believes that patients can contribute to their own health care and help make decisions easier by interacting with their physicians, direct communications with health care provider builds trust much needed for ultimate excellent outcomes. 

Clinical Interests

Dr Alnimri is a Transplant Nephrologist offering care to adults with kidney and Pancreas transplant. She evaluates patients for kidney and pancreas transplant and those interested in living kidney donation.

Research/Academic Interests

Dr. Alnimri is interested in clinical trials about new immunosuppression in the pipe line also desensitization protocols, follow up of living kidney donors and finding ways to diagnose rejection without doing kidney biopsies.


Transplant Nephrology

Center/Program Affiliation

Transplant Center

Medical School

M.B.B.S., Jordan University School of Medicine, Amman, Jordan 1987


Internal Medicine, Unity Health System, Rochester NY 2006-2008


Internal Medicine, Unity Health System, Rochester NY 2006-2008


Nephrology, Oregon Health Sciences University, Portland OR 1997-1999


Transplant Nephrology, UC San Francisco, San Francisco CA 2008-2009

Fellow of the Royal College of Physicians UK, 2005

Honorary Registrar University College, London, 2001

Jespersen Nizamic T, Huang Y, Alnimri M, Cheng M, Chen LX, Jen KY. COVID-19 Manifesting as Renal Allograft Dysfunction, Acute Pancreatitis, and Thrombotic Microangiopathy: A Case Report. Transplant Proc. 2021 May;53(4):1211-1214. doi:10.1016/j.transproceed.2020.10.048. Epub 2020 Dec 18. PMID:33436168.

Howard JH 3rd, Darrow M, Chen LX, Alnimri M, Jen KY. Tonsillar Kaposi sarcoma in a renal transplant patient. Transpl Infect Dis. 2020 Oct;22(5):e13347. doi:10.1111/tid.13347. Epub 2020 Jun 16. PMID:32495980.

Freidman G, Moss O, Alnimri M, Chen L. Determination of type 2 DM risk in potential living kidney donors : A single center protocol and experience. Transplantation. 2020 Sep;104(S3):S87-S88.

Chen LX, De Mattos A, Bang H, Vu CT, Gandhi M, Alnimri M, Gallay B, Fananapazir G. Angioplasty vs stent in the treatment of transplant renal artery stenosis. Clin Transplant. 2018 Apr;32(4):e13217. doi:10.1111/ctr.13217. Epub 2018 Feb 28. PMID:29394514.

Patel S, Pankewycz O, Kohli R, Said M, Alnimri M, Feng L, Laftavi MR. Obesity in renal transplantation: the role of induction therapy on long-term outcomes. Transplant Proc. 2011 Mar;43(2):469-71. doi:10.1016/j.transproceed.2011.01.040. PMID:21440736.

Alnimri M, Laftavi MR, Kohli R, Said M, Feng L, Patel S, Pankewycz O. African-American women and older patients are at risk for a greater decline in renal function following living kidney donation. Transplant Proc. 2011 Mar;43(2):512-5. doi:10.1016/j.transproceed.2011.01.041. PMID:21440747.

Laftavi MR, Alnimri M, Weber-Shrikant E, Kohli R, Said M, Patel S, Pankewycz O. Low-dose rabbit antithymocyte globulin versus basiliximab induction therapy in low-risk renal transplant recipients: 8-year follow-up. Transplant Proc. 2011 Mar;43(2):458-61. doi:10.1016/j.transproceed.2011.01.035. PMID:21440733.

Laftavi MR, Hai F, Laftavi H, Feng L, Said M, Patel S, Kohli R, Alnimri M, Dayton M, Pankewycz O. Mycophenolic acid dose reductions result in poor long-term renal allograft survival: comparison between mycophenolate sodium and mycophenolate mofetil. Transplant Proc. 2011 Mar;43(2):478-81. doi:10.1016/j.transproceed.2011.01.037. PMID:21440738.

Laftavi MR, Patel S, Soliman MR, Alnimri M, Kohli R, Said M, Pankewycz O. Low-dose thymoglobulin use in elderly renal transplant recipients is safe and effective induction therapy. Transplant Proc. 2011 Mar;43(2):466-8. doi:10.1016/j.transproceed.2011.01.039. PMID:21440735.

Pankewycz O, Leca N, Kohli R, Wallace PK, Said M, Feng L, Alnimri M, Patel S, Laftavi MR. Low-dose rabbit antithymocyte globulin induction therapy results in prolonged selective lymphocyte depletion irrespective of maintenance immunosuppression. Transplant Proc. 2011 Mar;43(2):462-5. doi:10.1016/j.transproceed.2011.01.034. PMID:21440734.